Related Experiment Video
Updated: Apr 14, 2026

09:50
A Revised Method for Inducing Secondary Lymphedema in the Hindlimb of Mice
Published on: November 2, 2019
8.8K
Minimizing Early-Onset Lymphedema Following Groin Dissection in Metastatic Melanoma
Melody Brown1, Teresa S Lee2,3, Isabel Li4
1Mater Hospital, Brisbane, Australia.
Annals of Surgical Oncology
|April 13, 2026
Summary
A 6-month program of compression garments and simple lymphatic drainage did not significantly reduce lymphedema incidence after groin dissection compared to standard care. Early benefits were not sustained after the intervention period ended.
Area of Science:
- Oncology
- Surgical Complications
- Lymphedema Management
Background:
- Lymphedema is a frequent and debilitating complication following groin dissection for metastatic melanoma.
- Effective prophylactic strategies are needed to mitigate this post-surgical burden.
Purpose of the Study:
- To evaluate the efficacy of a 6-month program of compression garments combined with simple lymphatic drainage (CG-SLD) in reducing lymphedema incidence post-groin dissection.
- To compare CG-SLD against standard care (SC) in preventing lymphedema development and severity.
Main Methods:
- A randomized controlled trial comparing CG-SLD to SC for 6 months post-surgery.
- Lymphedema assessment using interlimb volume difference and bioimpedance spectroscopy at baseline and every 3 months for 24 months.
- Primary endpoint: lymphedema incidence at 24 months; secondary outcomes: time to onset, severity, and quality of life (QoL).
Main Results:
- The study was underpowered with 38 participants randomized (SC: 20, CG-SLD: 18).
- Lymphedema incidence at 24 months was numerically higher in SC (55%) versus CG-SLD (38.9%), but this difference was not statistically significant.
- Early lymphedema severity favored CG-SLD at 3 months, but no persistent differences were observed. No significant QoL differences were found.
Conclusions:
- The CG-SLD intervention did not significantly reduce lymphedema incidence compared to SC at 24 months.
- Observed early benefits in lymphedema reduction were not maintained after the 6-month intervention period.
- Larger trials are necessary to confirm if early prophylactic strategies offer lasting benefits due to the study's underpowered nature.

